Federal and State Authorities Seek Contempt Ruling Against Martin Shkreli

Monterey Salinas, CA, October 13, 2026 —

Federal and state authorities have initiated legal action seeking to hold Martin Shkreli in contempt of court, alleging he has violated a court order that prohibits his involvement in the pharmaceutical industry. The complaint was filed by the Federal Trade Commission (FTC) along with attorneys general representing seven states.

According to the filings, Shkreli’s alleged violations stem from his activities following his release from prison. These activities reportedly include participation in stock trading and engagement through social media commentary. The court order in question was put in place to prevent him from continuing his practices within the pharmaceutical sector.

Shkreli was previously convicted of securities fraud, leading to his incarceration and the subsequent court order restricting his future business dealings in the pharmaceutical industry. The current contempt proceedings suggest that his recent actions are seen by regulators as direct contraventions of this judicial directive.

The specific details of the stock trading activities and the nature of his social media commentary that allegedly violate the order were not fully elaborated in the initial summary. The plaintiffs are asking the court to find Shkreli in contempt due to these alleged repeated violations of the long-standing injunction.

The outcome of this contempt proceeding could result in further sanctions against Shkreli. The exact penalties or remedies sought by the FTC and the state attorneys general were not provided in the summary.

Story summarized from the original created by CNN Newsource on kioncentralcoast.com, see more information here.

Media gallery